Toronto, Ontario (PRWEB) December 20, 2013
Hemostemix Ltd. announced today the formation and inaugural meeting of a clinical trial steering committee to guide the company in optimizing all aspects of the upcoming Phase 2 trial for its lead product, ACP-01, in patients with critical limb ischemia.
As well-respected specialists in critical limb ischemia and vascular surgery, the role of the Clinical Trial Steering Committee will be to advise the Company on all matters critical to the trial’s success.
“We are extremely honored with the caliber of key opinion leaders who have committed to providing us with their expertise on the trial’s design, implementation, sites, enrollment criteria, and several other critical parameters,” stated Hemostemix Founder and President, Dr. Valentin Fulga.
“We believe we have a real opportunity to learn valuable lessons from the committee’s collective experience in the space and translate that into a successful trial. The committee is providing valuable input in this regard,” continues Dr. Fulga, “and we were pleased to have what proved to be a very valuable inaugural meeting this week in Toronto.”
The committee is comprised of prominent clinician scientists, namely:
Mohammed Al-Omran, MD is Professor of Surgery at University of Toronto and King Saud University and Chief of Vascular Surgery Division at St Michael’s Hospital. Dr. Al-Omran is a clinician investigator and currently appointed as a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. His research interests are focused on atherosclerosis bench to bedside with special interest in peripheral arterial disease.
- Elmar R. Burchardt, MD, PhD, DS., is Professor of Clinical Pharmacology at the Univers
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Hemostemix Hosts Cell Therapy Industry Seminar2
. Hemostemix Announces Formation of Scientific Advisory Board3
. Hemostemix Announces US Patent Allowance4
. The Hemostemix Group of Companies Provides Corporate Strategy Update5
. What can happen when graphene meets a semiconductor6
. Discovery Meets Recovery in New Cedars-Sinai’s Advanced Health Sciences Pavilion Designed by HOK7
. Marken Meets Critical Demand For In Vitro Lab Shipments8
. SPIE ‘gold’ open access program meets new needs of UK authors -- and others9
. Origami meets chemistry in scholarly video-article10
. Veridiams Training Program Wins Accolades and Awards- Meets Skilled Labor Challenge Head On11
. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"